Tue Wenzel Kragstrup Selected Research

Tue Wenzel Kragstrup Research Topics

Disease

7	Arthritis (Polyarthritis) 04/2022 - 10/2010
7	Rheumatoid Arthritis 01/2022 - 01/2008
3	Neoplasms (Cancer) 04/2022 - 01/2010
3	Necrosis 01/2022 - 01/2008
2	Inflammation (Inflammations) 01/2022 - 10/2010
1	Reactive Arthritis (Reiter Disease) 04/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Microscopic Polyangiitis 06/2021
1	Takayasu Arteritis (Arteritis, Takayasu's) 06/2021
1	Giant Cell Arteritis (Horton Disease) 06/2021
1	Vasculitis (Vasculitides) 06/2021
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 06/2021
1	Churg-Strauss Syndrome (Allergic Angiitis) 06/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2021
1	End Stage Liver Disease 01/2021
1	Hypothyroidism 01/2020
1	Psoriatic Arthritis 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020
1	Infections 03/2016
1	Chronic Pain 03/2011
1	Spondylarthropathies 01/2008
1	Osteoarthritis 01/2008

Drug/Important Bio-Agent (IBA)

3	Immune Checkpoint InhibitorsIBA 04/2022 - 01/2020
3	CytokinesIBA 06/2021 - 01/2008
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2022 - 01/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 06/2021
2	Adalimumab (Humira)FDA Link 06/2021 - 01/2016
2	AutoantibodiesIBA 03/2016 - 01/2016
1	pembrolizumabIBA 01/2022
1	tofacitinibIBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	Janus KinasesIBA 01/2022
1	Etanercept (Enbrel)FDA Link 06/2021
1	Rituximab (Mabthera)FDA Link 06/2021
1	Complement System Proteins (Complement)IBA 06/2021
1	Infliximab (Remicade)FDA Link 06/2021
1	avacopanIBA 06/2021
1	tocilizumab (atlizumab)FDA Link 06/2021
1	Interleukin-5 (Interleukin 5)IBA 06/2021
1	mepolizumabIBA 06/2021
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 06/2021
1	Anaphylatoxin C5a ReceptorIBA 06/2021
1	vedolizumabIBA 02/2021
1	Abatacept (Orencia)FDA Link 02/2021
1	milk-derived factorIBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	GlucocorticoidsIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Interleukin-12 (IL 12)IBA 01/2020
1	InterleukinsIBA 01/2020
1	Antirheumatic Agents (DMARD)IBA 01/2020
1	DisintegrinsIBA 10/2016
1	Rheumatoid FactorIBA 03/2016
1	Anti-Citrullinated Protein AntibodiesIBA 03/2016
1	interleukin-20 receptorIBA 03/2016
1	Indicators and Reagents (Reagents)IBA 09/2014
1	Vitamin D FDA LinkGeneric 03/2011
1	IntegrinsIBA 10/2010
1	EpitopesIBA 10/2010
1	p38 Mitogen-Activated Protein KinasesIBA 01/2010
1	Interleukin-10 (Interleukin 10)IBA 01/2010
1	Interleukin-6 (Interleukin 6)IBA 01/2008
1	Messenger RNA (mRNA)IBA 01/2008
1	interleukin 20 (IL-20)IBA 01/2008

Therapy/Procedure

4	Therapeutics 04/2022 - 03/2016
1	Biological Therapy 06/2021
1	Injections 01/2020
1	Drug Therapy (Chemotherapy) 01/2010